Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > Similar drug gets breakthrough designation by FDA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by Tson99on Nov 27, 2014 9:59am
287 Views
Post# 23169236

RE:RE:RE:Similar drug gets breakthrough designation by FDA

RE:RE:RE:Similar drug gets breakthrough designation by FDAThis link is from May 31, 2014, I would think Bioniche management knows about this if it was really a nail in the coffin they would have changed their direction back in May.

https://www.roche.com/media/media_releases/med-cor-2014-05-31.htm
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities